Evidence map›Paper›PMID 35053770›Full record

ArticleBrain sciences2021

Secondary Impact of COVID-19 Pandemic on People with Parkinson's Disease-Results of a Polish Online Survey.

Karolina Krzysztoń, Beata Mielańczuk-Lubecka, Jakub Stolarski, Anna Poznańska, Katarzyna Kępczyńska, Agata Zdrowowicz, Izabela Domitrz, Jan Kochanowski

Open access · goldAbstract read
In one paragraph

Article in Brain sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 3 pooled it
1.4field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 3 syntheses or guidelines pooled it, 15 citations in OpenAlex.

  1. Pooled it
  2. Psychological outcomes of the COVID-19 pandemic in patients with Parkinson's disease: A systematic review.Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia · 2022
    Pooled it
  3. Pooled it
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Spotlight on non-motor symptoms and Covid-19.International review of neurobiology · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Karolina KrzysztońDepartment of Neurology, Faculty of Medical Sciences, Medical University of Warsaw, 01-809 Warsaw, Poland.ORCID 0000-0002-1658-9038
Beata Mielańczuk-LubeckaDepartment of Neurology, Faculty of Medical Sciences, Medical University of Warsaw, 01-809 Warsaw, Poland.
Jakub StolarskiDepartment of Neurology, Faculty of Medical Sciences, Medical University of Warsaw, 01-809 Warsaw, Poland.
Anna PoznańskaDepartment of Population Health Monitoring and Analysis, National Institute of Public Health NIH-National Research Institute, 00-791 Warsaw, Poland.
Katarzyna KępczyńskaDepartment of Neurology, Faculty of Medical Sciences, Medical University of Warsaw, 01-809 Warsaw, Poland.
Agata ZdrowowiczDepartment of Neurology, Faculty of Medical Sciences, Medical University of Warsaw, 01-809 Warsaw, Poland.
Izabela DomitrzDepartment of Neurology, Faculty of Medical Sciences, Medical University of Warsaw, 01-809 Warsaw, Poland.
Jan KochanowskiDepartment of Neurology, Faculty of Medical Sciences, Medical University of Warsaw, 01-809 Warsaw, Poland.
Medical University of Warsaw · PLNarodowy Instytut Zdrowia Publicznego PZH – Państwowy Instytut Badawczy · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The COVID-19 pandemic causes increased mental stress and decreased mobility, which may affect people with Parkinson's disease (PD). The study aimed to investigate the secondary impact of the COVID-19 pandemic on the level of activity, quality of life (QoL) and PD-related symptoms. The respondents completed an online survey in Polish in the period from December, 2020 to June, 2021. The questionnaire was completed by 47 participants aged 43 to 90 years (mean 72.1 ± 1.3 years). A total of 94% reported reduced contact with family and friends. Over 90% remained active during the pandemic. However, 55% of people with PD showed subjectively lower level of activity then before the pandemic. Moreover, 36% of the respondents felt afraid to visit a doctor and reported problems with access to medication. Subjective QoL reduction was reported by 80%, and 83% declared worsening of PD symptoms. The post pandemic deterioration of motor symptoms in people with PD did not affect their QoL. However, the deterioration of contacts and feelings of isolation had a significant impact on the decline in quality of life (

Indexed as

COVID-19pandemicParkinson’s disease

Identifiers

PMID35053770
PMCPMC8774235
OpenAlexW4200574635

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.